niagenbioscience.com (NAGE) - Ekuitas Perusahaan

NAGE (ChromaDex Corporation) - tandha merek perusahaan

This daily price chart for Chromadex Corp (NAGE) is recorded at 0.08. Chromadex Corp dominates the creation of patented components for cell metabolism, protecting itself from cheap imitations through intellectual property rights. Revenues are based on the production of biochemical supplements, where Niagen for dietary supplements serves as the key driver. Supply chain stability is ensured by streamlined industrial transportation of chemical raw materials to the plants.

NAGE Kapitalisasi Buku Chromadex Corp (20.03.2025 - 28.10.2026)

Chromadex Corp (NAGE) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Bagan kurs Niagen|NAGE - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar ChromaDex Corp|NAGE - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi saben Saham ChromaDex|NAGE - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku niagenbioscience.com|NAGE - Total Aset Perusahaan
- data utang lan likuiditas:
Rasio Utang marang Ekuitas Chromadex Corp|NAGE - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal niagenbioscience.com|NAGE - Gunggung utang perusahaan|Utang marang nilai buku ChromaDex Corp
Pambiji fundamental:NAGE - ChromaDex Corp.
Produk seri niagenbioscience.com

Book value reflects the actual value of the issuer's net assets minus all liabilities, determining the business's internal margin of safety. Analyzing the book value of Chromadex Corp (NAGE) allows for an assessment of the actual protection of investments against default. The metric is calculated as the difference between total assets and debts. For Chromadex Corp (NAGE), growth in this indicator confirms the effectiveness of its patent monopoly on Nicotinamide Riboside. Stable capital accumulation solidifies the company's dominance in the B2B sector of anti-aging biotechnology.

Analisis pesaing Chromadex Corp

ISRG - Nilai Buku Bisnis|Kapitalisasi Buku DHR|BDX (bd.com) - Ekuitas Perusahaan|Nilai Buku Perusahaan STE|Aset Bersih Perusahaan West Pharma|Baxter Corp - Kapitalisasi Buku|Ekuitas Perusahaan Masimo Inc. (MASI)|STVN - Kapitalisasi Buku|Kapitalisasi Akuntansi teleflex.com TFX|Kapitalisasi Buku MMSI (Merit Medical)|NVST - Pambiji Buku Bisnis|ICUI (ICU Medical Corp) - Kapitalisasi Buku|Sirona Dental Systems (XRAY) - Aset Bersih Perusahaan|LMAT (LeMaitre Vascular, Inc.) - Kapitalisasi Buku|Kapitalisasi Buku ATRC|Nilai Buku Perusahaan STAAR Surgical (STAA)|Nilai Buku Perusahaan ZimVie Inc ZIMV|Aset Bersih Perusahaan AngioDynamics Corp|Nilai Akuntansi Perusahaan Cerus Inc CERS|Kapitalisasi Buku TKNO (Alpha Teknova, Inc.)|MGRM: Pambiji Buku Bisnis|Nilai Buku Perusahaan sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Kapitalisasi Akuntansi|UTMD: Nilai Buku Perusahaan|Pambiji Buku Bisnis KORU Medical Systems Inc. (KRMD)|Aset Bersih Perusahaan Nyxoah S.A.|Total Aset Bersih MBOT (microbotmedical.com)|Nilai Buku Perusahaan Pro-Dex|ZTEK - Nilai Akuntansi Perusahaan|Elutia Corp - Aset Bersih Perusahaan|MLSS: Kapitalisasi Buku|NXGL (NEXGEL, Inc.) - Nilai Buku Perusahaan|Retractable Technologies, Inc. (RVP) - Aset Bersih Perusahaan|Kapitalisasi Buku HBIO (Harvard Bioscience, Inc.)|Ekuitas Perusahaan FEMY|Nilai Buku Perusahaan MeihuaMed MHUA|Kapitalisasi Akuntansi predictive-oncology.com POAI|Aset Bersih Perusahaan Callan JMB (CJMB)|atrioncorp.com - Total Aset Bersih|Nilai Buku Perusahaan NURO (NeuroMetrix)